PDT Partners’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

PDT Partners’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5,107	Closed	-$409K	–	550
2018 Q3	$409K	Sell	5,107 -46,799	-90%	-$4.36M	0.02%	379
2018 Q2	$5.16M	Sell	51,906 -12,594	-20%	-$1.09M	0.2%	159
2018 Q1	$5.22M	Buy	+64,500	New	+$5.21M	0.18%	161
2015 Q4	–	Sell	-18,800	Closed	-$1.69M	–	1197
2015 Q3	$1.69M	Sell	18,800 -13,832	-42%	-$1.46M	0.04%	524
2015 Q2	$3.76M	Buy	32,632 +4,872	+18%	+$512K	0.1%	259
2015 Q1	$2.65M	Buy	27,760 +19,456	+234%	+$1.46M	0.07%	366
2014 Q4	$558K	Buy	8,304 +1,015	+14%	+$62.9K	0.05%	435
2014 Q3	$393K	Buy	7,289 +585	+9%	+$28.8K	0.01%	1021
2014 Q2	$298K	Buy	+6,704	New	+$274K	0.01%	1197
2013 Q3	–	Sell	-24,531	Closed	-$563K	–	1844
2013 Q2	$563K	Buy	+24,531	New	+$619K	0.01%	1017

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PDT Partners's CBPO Position: Q4 2018 in Review

PDT Partners sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2018, closing a stake of 5,107 shares — an estimated $409K sold.

PDT Partners first reported a position in CBPO in Q2 2013 and held it in 10 quarters. The position peaked at $5.22M in Q1 2018. 67 funds tracked by Wall St. Rank hold CBPO as of Q4 2018.

PDT Partners reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2018 after selling out during the quarter.
PDT Partners sold 5,107 China Biologic Products Holdings, Inc. shares in Q4 2018, an estimated $409K.
PDT Partners first reported a position in China Biologic Products Holdings, Inc. in Q2 2013 and held it in 10 quarters.
PDT Partners's China Biologic Products Holdings, Inc. position peaked at $5.22M in Q1 2018.
67 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2018.

Based on PDT Partners's 13F filing for Q4 2018, filed 14 Feb 2019.